Ipsen is a France-based biopharmaceutical group operating globally through two segments: Specialty Care and Consumer Healthcare. In Specialty Care, the Company is focused on various therapeutic areas, including oncology, neurosciences and rare diseases. In addition, the Company has specialism in neurotoxin research and operates three research and development centres located in France, the United Kingdom and the United States.